
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
Fei Wang, Cai Guang, Yingchao Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 15
Fei Wang, Cai Guang, Yingchao Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 15
Showing 15 citing articles:
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Advances and applications of RNA vaccines in tumor treatment
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer
Bo Zhang, Yi Pan, Zhe Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Bo Zhang, Yi Pan, Zhe Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Development and Characterization of a miRNA-Responsive Circular RNA Expression System with Cell-Type Specificity
Yu Ma, Yan Mao, Shirui Luo, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102450-102450
Open Access
Yu Ma, Yan Mao, Shirui Luo, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102450-102450
Open Access
Recent advances and perspectives on the development of circular RNA cancer vaccines
Zhaohui Gong, Wentao Hu, Chengwei Zhou, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Zhaohui Gong, Wentao Hu, Chengwei Zhou, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Role of the circRNA/miRNA/mRNA axis in Renal Cell Carcinoma: from gene regulation to metabolism and immunity
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Roles of circRNAs in viral pathogenesis
Jiayin Liu, Yiming Wang, Meichun Zheng, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Jiayin Liu, Yiming Wang, Meichun Zheng, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Advancements and challenges in personalized neoantigen-based cancer vaccines
Parminder Singh, Mahalaqua Nazli Khatib, R Roopashree, et al.
Oncology Reviews (2025) Vol. 19
Open Access
Parminder Singh, Mahalaqua Nazli Khatib, R Roopashree, et al.
Oncology Reviews (2025) Vol. 19
Open Access
Optimized circular RNA vaccines for superior cancer immunotherapy
Hongwu Yu, Yifan Wen, Wenqian Yu, et al.
Theranostics (2024) Vol. 15, Iss. 4, pp. 1420-1438
Open Access | Times Cited: 3
Hongwu Yu, Yifan Wen, Wenqian Yu, et al.
Theranostics (2024) Vol. 15, Iss. 4, pp. 1420-1438
Open Access | Times Cited: 3
The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases
Lu-Xuan Yang, Hui Li, Zhihui Cheng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3055-3055
Open Access
Lu-Xuan Yang, Hui Li, Zhihui Cheng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3055-3055
Open Access
Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access
CircRNAs in the Tumor Microenvironment: New Frontiers in Cancer Progression and Therapy
Y Guo, Yuanxun Gong, Man Wu, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 212, pp. 104754-104754
Closed Access
Y Guo, Yuanxun Gong, Man Wu, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 212, pp. 104754-104754
Closed Access
Advances in Engineering Circular RNA Vaccines
Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 692-692
Open Access | Times Cited: 3
Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 692-692
Open Access | Times Cited: 3
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
Uddalak Das, Soupayan Banerjee, Meghna Sarkar, et al.
Cancer Pathogenesis and Therapy (2024)
Open Access | Times Cited: 2
Uddalak Das, Soupayan Banerjee, Meghna Sarkar, et al.
Cancer Pathogenesis and Therapy (2024)
Open Access | Times Cited: 2
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
Ziqi Cheng, Junfeng Ma, Chenyan Zhao
Vaccines (2024) Vol. 12, Iss. 12, pp. 1382-1382
Open Access | Times Cited: 2
Ziqi Cheng, Junfeng Ma, Chenyan Zhao
Vaccines (2024) Vol. 12, Iss. 12, pp. 1382-1382
Open Access | Times Cited: 2